ZLAB
Zai Lab LimitedNASDAQHealthcare$20.41+0.44%ClosedMarket Cap: $2.26B
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
3.11
P/S
4.93
EV/EBITDA
-9.92
DCF Value
$-76.76
FCF Yield
-6.8%
Div Yield
0.0%
Margins & Returns
Gross Margin
58.5%
Operating Margin
-49.9%
Net Margin
-38.1%
ROE
-22.8%
ROA
-15.0%
ROIC
-23.3%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $127.6M | 51.2% | $-69.4M | $-50.4M | $-0.46 | — |
| FY 2025 | $460.2M | 58.6% | $-229.4M | $-175.5M | $-1.60 | — |
| Q3 2025 | $116.1M | 59.6% | $-48.8M | $-36.0M | $-0.33 | — |
| Q2 2025 | $110.0M | 60.7% | $-54.9M | $-40.7M | $-0.37 | — |
| Q1 2025 | $106.5M | 63.7% | $-56.3M | $-48.4M | $-0.45 | — |
| Q4 2024 | $109.1M | 61.4% | $-67.9M | $-81.7M | $-0.80 | — |
| FY 2024 | $399.0M | 62.9% | $-282.1M | $-257.1M | $-2.60 | — |
| Q3 2024 | $102.3M | 63.9% | $-67.9M | $-41.7M | $-4.30 | — |
| Q2 2024 | $100.5M | 64.9% | $-76.1M | $-80.3M | $-8.20 | — |
| Q1 2024 | $87.1M | 61.4% | $-70.3M | $-53.5M | $-5.50 | — |
| Q4 2023 | $65.8M | 61.7% | $-124.0M | $-95.4M | $-9.80 | — |
| FY 2023 | $266.7M | 64.1% | $-366.6M | $-334.6M | $-34.60 | — |